<\/p>\n\n\n\n
OPPORTUNITIES FOR ADVOCACY<\/h1>\n\n\n\n
September 20th FDA Listening Session: <\/strong>Patient and Care Partner Perspectives on Safety Considerations for Approved Gene Therapy Treatments for Rare Diseases<\/p>\n\n\n\n October 16th FDA Stakeholder Listening Session:<\/strong> Advancing Rare Disease Therapies Through an FDA Rare Disease Innovation Hub<\/p>\n\n\n\n <\/p>\n\n\n\n \u201cDespite these limitations, our results show a link between infections, accelerated brain atrophy and increased dementia risk, while highlighting the immunological proteins by which infections may contribute to neurodegeneration.\u201d<\/p>\n\n\n\n Read Full Paper Here.<\/a><\/p>\n\n\n\n “An increasing body of research suggests that AD may be linked to exposure to bacterial and viral infections, including spirochetes, oral bacterial species, gastrointestinal microbes, and herpesviruses. Host immune response to infectious agents may initiate or accelerate AD processes, such as the accumulation of amyloid beta (A\u03b2), pathogenic tau protein, and neuroinflammation. Particularly in brain regions with AD pathology, infectious agents and their related molecules may breach blood-brain barriers, accelerate A\u03b2 deposition, and trigger neurotoxic microglial activation, resulting in a cycle of neurodegeneration brought on by pathogen-associated molecular patterns (PAMPs).”<\/p>\n\n\n\n Read the Full Paper Here. <\/p>\n\n\n\n <\/p>\n\n\n\n September 23<\/p>\n\n\n\n <\/p>\n<\/div>\n\n\n\n September 19<\/p>\n\n\n\n Excision BioTherapeutics Announces Publication in Molecular Therapy Methods & Clinical Development Highlighting EBT-104 for the Treatment of HSV-1 Keratitis<\/a><\/p>\n\n\n\n Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop<\/a><\/p>\n\n\n\n Kimer Med (New Zealand) and Excision Biotherapeutics Included in Fierce Biotech’s 2024 Fierce 15<\/a><\/p>\n\n\n\n NEW IN THE PIPELINE: Biotech Red Queen launches with $55M to build versatile antivirals <\/p>\n\n\n\n Every donation \u2013 whether $10 or $10,000 \u2013 moves us closer to a world where herpes is effectively treated and free from stigma.<\/em><\/p>\n\n\n\n Questions about giving?<\/strong>\u00a0Contact us at\u00a0info@herpescureadvocacy.com<\/a>\u00a0or 302-307-3560.<\/p>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"NEW RESEARCH DOCUMENTING HERPES IMPACT ON BRAIN HEALTH, ALZHEIMERS AND DEMENTIA<\/h1>\n\n\n\n
Proteomics identifies potential immunological drivers of post-infection brain atrophy and cognitive decline<\/h6>\n\n\n\n
Infection burden, periodontal pathogens, and their interactive association with incident all-cause and Alzheimer’s disease dementia in a large national survey<\/h5>\n\n\n\n
<\/a><\/p>\n\n\n\nEVENTS<\/h1>\n\n\n\n
Living with Meningitis<\/h5>\n\n\n\n
![\"\"](\"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2024\/04\/Services_primary-care-jpeg.webp?resize=750%2C509&ssl=1\")
<\/figure>\n<\/div><\/div>\n\n\n\nAdvancing Science HCA and HVTN Present: NIH Strategic Research Plan for Herpes <\/h5>\n<\/div>\n\n\n\n
![\"\"](\"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2024\/08\/Advancing-Science-Header-Instagram-Post.png?resize=750%2C750&ssl=1\")
<\/figure>\n<\/div>\n\n\n\nNEWS FROM THE PIPELINE<\/h2>\n\n\n\n
<\/a><\/p>\n\n\n\nJoin Herpes Cure Advocacy as a Member<\/h2>\n\n\n\n
\n\n\n\n![\"\"](\"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2023\/04\/Document2.png?resize=750%2C750&ssl=1\")
<\/figure>Give Today and Join the Fight \u2192<\/a><\/strong><\/h6>\n\n\n\n